Top Page
OXIDE Corp.
(6521)
OXIDE Corp. (6521) vs. iShares MSCI Japan ETF (EWJ)
OXIDE Corp. Business Overview & Revenue Model
OXIDE Corp. Financial Statement Overview
| Breakdown | TTM | Feb 2025 | Feb 2024 | Feb 2023 | Feb 2022 | Feb 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 8.79B | 8.39B | 6.61B | 5.75B | 4.76B | 3.58B |
| Gross Profit | 3.61B | 3.06B | 1.88B | 2.28B | 1.63B | 1.08B |
| EBITDA | 1.13B | -1.67B | 558.00M | 1.03B | 890.92M | 653.30M |
| Net Income | -2.72B | -2.70B | -422.30M | 557.39M | 495.74M | 310.46M |
Balance Sheet | ||||||
| Total Assets | 17.51B | 18.21B | 19.25B | 10.79B | 8.71B | 6.57B |
| Cash, Cash Equivalents and Short-Term Investments | 2.56B | 2.25B | 1.63B | 1.44B | 2.15B | 1.18B |
| Total Debt | 10.36B | 10.37B | 9.21B | 3.68B | 2.62B | 3.79B |
| Total Liabilities | 12.46B | 12.79B | 11.64B | 5.56B | 4.12B | 5.05B |
| Stockholders Equity | 5.05B | 5.41B | 7.61B | 5.23B | 4.59B | 1.51B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -775.41M | -2.72B | -1.62B | -382.82M | 281.26M |
| Operating Cash Flow | 0.00 | 885.16M | -953.77M | -119.25M | 443.38M | 568.30M |
| Investing Cash Flow | 0.00 | -1.54B | -6.14B | -1.73B | -849.16M | -300.64M |
| Financing Cash Flow | 0.00 | 1.28B | 7.30B | 1.12B | 1.38B | 241.38M |
OXIDE Corp. Technical Analysis
OXIDE Corp. Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥176.48B | 16.57 | ― | 1.53% | 3.37% | 21.35% | |
72 Outperform | ¥51.59B | 12.37 | ― | 0.91% | 5.28% | 18.38% | |
72 Outperform | ¥140.24B | 3.86 | 8.07% | 2.64% | 79.29% | 35.48% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
60 Neutral | ¥316.54B | 35.22 | ― | 2.29% | -13.21% | -54.83% | |
59 Neutral | ¥51.00B | 195.39 | ― | 5.01% | -32.74% | -117.06% | |
53 Neutral | ¥51.51B | -105.37 | ― | ― | 36.90% | -311.02% |
OXIDE Corp. Corporate Events
OXIDE Corporation reported the February 2026 exercise status of its sixth series stock acquisition rights, disclosing that 4,000 shares were delivered through the exercise of four option units. Following these exercises, unexercised stock acquisition rights declined from 572 units to 568 units, corresponding to a potential 568,000 shares.
As of the end of February, the company had 11,567,113 issued shares excluding dilutive securities, with the remaining 568,000 shares from unexercised stock options classified as dilutive. Including these potential shares, OXIDE’s fully diluted share count would total 12,135,113 shares, offering investors updated visibility into possible future share dilution.
The most recent analyst rating on (JP:6521) stock is a Buy with a Yen3531.00 price target. To see the full list of analyst forecasts on OXIDE Corp. stock, see the JP:6521 Stock Forecast page.
OXIDE Corporation has completed the transfer of all shares and loan receivables of its Israeli consolidated subsidiary, Raicol Crystals Ltd., to Israel Special Material Platform LP, leading to Raicol’s removal from the company’s consolidated scope. The divestment will result in an extraordinary loss of about JPY 1.7 billion for the fiscal year ending February 2026, though the company emphasizes that this impact is accounting-based and will not affect its cash flow, signaling a strategic portfolio shift with limited immediate liquidity implications.
The most recent analyst rating on (JP:6521) stock is a Buy with a Yen3399.00 price target. To see the full list of analyst forecasts on OXIDE Corp. stock, see the JP:6521 Stock Forecast page.
OXIDE Corporation has revised its full-year consolidated earnings forecast, projecting a roughly 13.6% increase in revenue driven by strong standalone performance at OXIDE despite declining orders at its Israeli subsidiary Raicol Crystals. Robust demand in the Semiconductor business—particularly for deep ultraviolet lasers, single crystals, and next-generation laser development contracts—alongside increased shipments of Faraday rotators for data centers in its Frontier Tech segment, is expected to lift operating profit about 12.5% above the previous forecast and significantly boost ordinary profit, even as Raicol incurs an operating loss due to geopolitical and cost pressures. However, the company now expects a net loss for the year, reflecting the planned transfer of all Raicol shares and related loan receivables and other below-operating-line impacts, highlighting a strategic shift to refocus on OXIDE’s higher-growth, more profitable core businesses while exiting a loss-making overseas operation.
The most recent analyst rating on (JP:6521) stock is a Hold with a Yen1825.00 price target. To see the full list of analyst forecasts on OXIDE Corp. stock, see the JP:6521 Stock Forecast page.
OXIDE Corporation has decided to transfer all shares and loan receivables of its Israeli consolidated subsidiary Raicol Crystals Ltd., removing it from the scope of consolidation and recognizing an extraordinary loss. Raicol, acquired in 2023 to expand OXIDE’s product portfolio and European sales network, has seen a sharp business deterioration following the outbreak of the Israel conflict, with employee mobilization, boycotts of Israeli products in markets such as Turkey and parts of Europe, and a resulting collapse in orders across key applications; despite cost-cutting measures, Raicol is now expected to post a significant operating loss, prompting OXIDE to exit the business to limit further financial and operational drag.
The most recent analyst rating on (JP:6521) stock is a Hold with a Yen1825.00 price target. To see the full list of analyst forecasts on OXIDE Corp. stock, see the JP:6521 Stock Forecast page.
OXIDE Corporation revised its full-year consolidated forecast for the fiscal year ending February 2026, projecting higher revenue and operating profit driven by stronger demand in its core Semiconductor business and the launch of a new Faraday rotator project for data centers in its Frontier Tech segment. However, despite an expected boost to ordinary profit from foreign exchange gains and an income tax benefit tied to increased deferred tax assets, the company now anticipates a net loss of ¥500 million for the year due to a roughly ¥1.7 billion extraordinary loss from the transfer of all shares and loans related to its subsidiary Raicol, highlighting both the operational momentum in its core businesses and the financial impact of portfolio restructuring on shareholders.
The most recent analyst rating on (JP:6521) stock is a Hold with a Yen1825.00 price target. To see the full list of analyst forecasts on OXIDE Corp. stock, see the JP:6521 Stock Forecast page.
OXIDE Corporation reported that while standalone sales for the nine months ended November 30, 2025 rose 11% year-on-year and remained profitable, its Israeli subsidiary Raicol continues to post operating losses, weighing on consolidated results. Management attributed Raicol’s ongoing losses to a persistently challenging external environment, including regional boycotts linked to the Israel conflict and higher inflation-driven raw material and other costs, which worsened the profit structure despite revenue growth in the third quarter. Due to these uncertainties, the company stated it is extremely difficult to forecast Raicol’s future performance but, supported by recovery initiatives at the standalone OXIDE business, it sees no need to revise its full-year earnings forecast at this time. The company emphasized that restoring Raicol’s profitability is a key management issue and said it is exploring a broad range of strategic options to maximize overall group corporate value, signaling potential structural or strategic changes ahead for the subsidiary.
The most recent analyst rating on (JP:6521) stock is a Hold with a Yen1785.00 price target. To see the full list of analyst forecasts on OXIDE Corp. stock, see the JP:6521 Stock Forecast page.
OXIDE Corporation has reported non-operating income in the form of foreign exchange gains for the third quarter of its fiscal year ending February 28, 2026, driven primarily by the revaluation of intra-group loans to an overseas subsidiary. The company booked a foreign exchange gain of JPY 101 million in the third quarter alone and, combined with gains recorded in the second quarter, reported a cumulative foreign exchange gain of JPY 162 million for the current consolidated period; however, management has decided not to revise its existing full-year earnings forecast at this time, noting that such gains are sensitive to currency movements and indicating that any future revisions will be disclosed if conditions warrant.
The most recent analyst rating on (JP:6521) stock is a Hold with a Yen1785.00 price target. To see the full list of analyst forecasts on OXIDE Corp. stock, see the JP:6521 Stock Forecast page.
OXIDE Corporation reported consolidated net sales of ¥6.36 billion for the nine months ended November 30, 2025, an 11.1% year-on-year increase, while narrowing its loss, with operating loss improving to ¥258 million and net loss to ¥313 million compared with a much larger deficit a year earlier. Total assets declined slightly to ¥17.33 billion and the capital adequacy ratio rose to 30.7%, while the company maintained a zero-dividend policy for the current fiscal year; management left its full-year forecast unchanged, projecting a return to profitability with ¥8.71 billion in sales and ¥409 million in operating profit, signaling a gradual recovery trajectory that, if achieved, would improve earnings per share and financial stability for shareholders after consecutive loss-making periods.
The most recent analyst rating on (JP:6521) stock is a Hold with a Yen1785.00 price target. To see the full list of analyst forecasts on OXIDE Corp. stock, see the JP:6521 Stock Forecast page.
OXIDE Corporation reported the December 2025 exercise status of its 3rd series stock acquisition rights, with 7,000 shares delivered through the exercise of seven stock option units during the month. The 3rd series options reached the end of their exercise period on December 22, 2025, leaving 62 unexercised rights (equivalent to 62,000 shares) that were extinguished, thereby reducing the company’s potential dilutive shares by the same amount. As of the end of December, the company had 11,563,113 issued shares excluding dilutive securities and 572,000 remaining dilutive shares from stock acquisition rights, for a total of 12,135,113 shares on a fully diluted basis, providing investors with updated visibility into its equity base and dilution profile.
The most recent analyst rating on (JP:6521) stock is a Hold with a Yen1578.00 price target. To see the full list of analyst forecasts on OXIDE Corp. stock, see the JP:6521 Stock Forecast page.